Published in Psychiatr Genet on August 01, 2015
The genetics of anxiety-related negative valence system traits. Am J Med Genet B Neuropsychiatr Genet (2016) 0.79
2-arachidonoylglycerol signaling impairs short-term fear extinction. Transl Psychiatry (2016) 0.75
Modulation of defensive reactivity by GLRB allelic variation: converging evidence from an intermediate phenotype approach. Transl Psychiatry (2017) 0.75
Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry (2003) 2.89
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling? Am J Med (2012) 2.78
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry (2009) 2.09
The risk of overweight in children and adolescents with major mental illness. South Med J (2008) 2.05
SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell (2011) 1.86
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism. Arch Gen Psychiatry (2008) 1.75
Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence. Am J Med Genet B Neuropsychiatr Genet (2009) 1.68
Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci Lett (2007) 1.54
Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. Am J Psychiatry (2007) 1.43
Lack of effect of central nervous system-active doses of nabilone on capsaicin-induced pain and hyperalgesia. Clin Exp Pharmacol Physiol (2012) 1.42
A twin study of the genetics of fear conditioning. Arch Gen Psychiatry (2003) 1.30
Posttraumatic stress disorder: clinical features, pathophysiology, and treatment. Am J Med (2006) 1.17
Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. J Alzheimers Dis (2009) 1.06
The AVPR1A gene and substance use disorders: association, replication, and functional evidence. Biol Psychiatry (2011) 1.02
Cannabinoid receptor 1 gene association with nicotine dependence. Arch Gen Psychiatry (2008) 1.01
A longitudinal twin study of fears from middle childhood to early adulthood: evidence for a developmentally dynamic genome. Arch Gen Psychiatry (2008) 0.99
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia. J Alzheimers Dis (2013) 0.97
Effects of sleep or food deprivation during civilian survival training on cognition, blood glucose and 3-OH-butyrate. Wilderness Environ Med (2011) 0.93
Endorsement frequencies and factor structure of DSM-III-R and DSM-IV Generalized Anxiety Disorder symptoms in women: implications for future research, classification, clinical practice and comorbidity. Int J Methods Psychiatr Res (2005) 0.92
Childhood separation anxiety disorder and adult onset panic attacks share a common genetic diathesis. Depress Anxiety (2012) 0.90
Parenting and risk for mood, anxiety and substance use disorders: a study in population-based male twins. Soc Psychiatry Psychiatr Epidemiol (2013) 0.89
A genomewide association study of citalopram response in major depressive disorder-a psychometric approach. Biol Psychiatry (2010) 0.88
Assessment of generalized anxiety disorder diagnostic criteria in the National Comorbidity Survey and Virginia Adult Twin Study of Psychiatric and Substance Use Disorders. Psychol Assess (2008) 0.88
Follow-up association study of novel neuroticism gene MAMDC1. Psychiatr Genet (2009) 0.83
Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia. J Alzheimers Dis (2013) 0.83
The genetic covariation between fear conditioning and self-report fears. Biol Psychiatry (2007) 0.82
Support for involvement of glutamate decarboxylase 1 and neuropeptide Y in anxiety susceptibility. Am J Med Genet B Neuropsychiatr Genet (2012) 0.81
Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease. J Alzheimers Dis (2012) 0.81
Heritability of obsessive-compulsive symptom dimensions. Am J Med Genet B Neuropsychiatr Genet (2008) 0.80
Genetic association study between RGS2 and anxiety-related phenotypes. Psychiatr Genet (2013) 0.80
Association study between GABA receptor genes and anxiety spectrum disorders. Depress Anxiety (2009) 0.80
A case of aripiprazole-related tardive akathisia and its treatment with ropinirole. J Clin Psychiatry (2007) 0.79
Meta-analyses of genome-wide linkage scans of anxiety-related phenotypes. Eur J Hum Genet (2012) 0.78
Influence of lithium treatment on GDNF serum and CSF concentrations in patients with early Alzheimer's disease. Curr Alzheimer Res (2011) 0.77
Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia. Clin Exp Pharmacol Physiol (2013) 0.77
An association between Epac-1 gene variants and anxiety and depression in two independent samples. Am J Med Genet B Neuropsychiatr Genet (2010) 0.77
Obsessive compulsive symptom dimensions and neuroticism: An examination of shared genetic and environmental risk. Am J Med Genet B Neuropsychiatr Genet (2014) 0.77
Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials. J Alzheimers Dis (2012) 0.76
Test-Retest Reliability of the Facial Expression Labeling Task. Psychol Assess (2017) 0.75